1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321
942.50 5.25 (0.56%)
966.4K
NSE+BSE Volume

NSE 28 Nov, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Zydus Life gets US FDA nod for Empagliflozin & Linagliptin tablets with a market size of $215.8 mn See details


Zydus Lifesciences Earnings/Conference Calls

Zydus Lifesciences earnings concalls and investor presentations

864 Votes:
Buy 81.94%
Sell 9.95%
Hold 8.1%
BUY
SELL
HOLD
Accumulate SEE REPORTS >
All reports of ZYDUSLIFE